Latest News
Conference Coverage
Immunotherapy drug boosts survival in newly diagnosed ALL
First-line treatment with expensive medication should become standard, researcher says.
Feature
COVID booster shot poll: People ‘don’t think they need one’
A new poll shows why so few people are willing to get the latest COVID booster.
Feature
Multiple myeloma diagnosed more via emergency care during COVID
While trying to avoid COVID-19 infection, patients ultimately diagnosed with multiple myeloma may have delayed interactions with healthcare...
Feature
Rise of ‘alarming’ subvariants of COVID ‘worrisome’ for winter
This means people have no or “markedly reduced” protection against infection from these four strains.
News
FDA approves first gene therapy for bladder cancer
The U.S. Food and Drug Administration
- ...
Conference Coverage
Most women with breast cancer elude serious COVID-19 vaccine side effects
The frequency of lymph node swelling was similar to the general population.
Conference Coverage
Breast cancer diagnoses worse among Hispanics during COVID-19 pandemic
A study in San Antonio suggests low insurance coverage rates may be at least partially to blame.
Conference Coverage
Structural racism tied to later-stage breast cancer diagnoses
Black patients were more likely to be diagnosed with triple-negative breast cancer than White patients.
Conference Coverage
Adjuvant chemo tied to better survival in low-risk node-positive breast cancer
The survival advantage was present in all patients under 50 years old.
From the Journals
New test that detects 14 cancers focuses on sugars, not DNA
“The main advantage of glycosaminoglycans appears to be that they change in the blood and urine at the earliest stages of cancer.”
Conference Coverage
Exciting advances in HR-positive breast cancer: Top five picks from SABCS
Treatments meet unmet need and address unanswered questions.